CIK 0001921865 · <br>Emerging growth company
ASP Isotopes Inc.
Sign in to watch- Ticker
- ASPI
- Exchange
- Nasdaq
- Industry
- Miscellaneous Chemical Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 872618235
- Phone
- 202-756-2245
- Business address
- 2200 ROSS AVENUE, SUITE 4575E, DALLAS, TX, 75201
- 4 Planned sale Director sold 11,642 shares at $5.21 ($60,597)
- 4 Planned sale COO sold 25,000 shares at $4.51 ($112,775)
- 4 Planned sale COO sold 8,438 shares at $5.44 ($45,894)
- 4 Planned sale Executive Chairman sold 162,153 shares at $5.44 ($881,464)
- 4 Open-market sale Chief Financial Officer sold 80,000 shares at $5.80 ($463,840)
- 4 Grant or award Director acquired 36,548 shares (grant or award)
- 4 Grant or award Director acquired 36,548 shares (grant or award)
- 4 Grant or award Director acquired 36,548 shares (grant or award)
- 4 Grant or award Director acquired 36,548 shares (grant or award)
- 4 Planned sale Interim CEO and COO sold 8,438 shares at $6.20 ($52,341)
- 4 Planned sale Executive Chairman sold 162,153 shares at $5.75 ($932,866)
- 4 Grant or award Director acquired 10,470 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP, Gen Counsel, Secretary acquired 400,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Interim CEO and COO sold 25,000 shares at $5.77 ($144,225)
- 4 Planned sale Executive Officer sold 162,500 shares at an average $6.97 ($1,132,988)
- 4 Planned sale Interim CEO and COO sold 67,500 shares at $7.51 ($506,723)
- 4 Grant or award Director acquired 25,469 shares (grant or award)
- 4 Planned sale Interim CEO and COO sold 22,500 shares at $13.60 ($305,978)
Page 2 of 6 · 104 filings